Surge 2.0 Pineapple
On sale on the US market (according to the DSLD)
Advanced Nutrition Systems, food supplement from the US market
Surge 2.0 Pineapple (Advanced Nutrition Systems), a food supplement au code-barres 814995020086, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Advanced Nutrition Systems
- Barcode
- 814995020086
- Form
- Powder
- One serving
- 21.88 g
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Citric Acid, Natural Flavors, Calcium Silicate, Sucralose, Silicon Dioxide, Acesulfame Potassium, Yellow Color
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 40 Calorie(s) |
| Total Carbohydrates | Carbohydrate | 10 Gram(s) |
| Sodium | Mineral | 5 mg |
| Surge 2.0 Blend | Blend | 20,645 mg |
| Amino Recovery Blend | Blend | 10,701 mg |
| Maltodextrin | Carbohydrate | not stated |
| Waxy Maize | Carbohydrate | not stated |
| L-Glutamine | Amino acid | not stated |
| L-Leucine | Amino acid | not stated |
| L-Histidine | Amino acid | not stated |
| L-Ornithine AKG | Other substance | not stated |
| L-Isoleucine | Amino acid | not stated |
| L-Valine | Amino acid | not stated |
| Amla extract (Phyllanthus emblica) | Plant | not stated |
| Nitrovascular Blend | Blend | 5,030 mg |
| CarnoSyn | Amino acid | not stated |
| L-Arginine AKG | Other substance | not stated |
| L-Citrulline DL Malate | Other substance | not stated |
| L-Arginine | Amino acid | not stated |
| L-Arginine DL Malate | Other substance | not stated |
| L-Norvaline | Amino acid | not stated |
| Agmatine Sulfate | Other substance | not stated |
| ATP Volumizing Blend | Blend | 3,010 mg |
| Kre-Alkalyn | Other substance | not stated |
| Creatine MagnaPower | Other substance | not stated |
| Creatine Monohydrate | Other substance | not stated |
| Creatine HCl | Other substance | not stated |
| Extreme Energy/Focus Blend | Blend | 1,904 mg |
| Taurine | Other substance | not stated |
| Caffeine Anhydrous | Other substance | 295 mg |
| N-Acetyl L-Tyrosine | Other substance | not stated |
| Synephrine HCl | Other substance | not stated |
| Kola Nut powder | Plant | not stated |
| Rutaecarpine | Other substance | not stated |
| Di-Caffeine Malate | Other substance | not stated |
| Mucuna pruriens extract (Mucuna pruriens) | Plant | not stated |
| Phosphatidyl Serine powder | Fat | not stated |
| Huperzine A | Other substance | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Amla extract
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Advanced Nutrition Systems
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Surge 2.0 Pineapple (Advanced Nutrition Systems): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/814995020086-surge-2-0-pineapple-advanced-nutrition-systems, updated 31 August 2018.